Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft

Sep.19.2024
Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft
Indonesia's Health Ministry is asked to suspend discussions on tobacco and e-cigarette safety regulations, sparking industry concerns.

According to a report from Metrotv News on September 18, the Indonesian Ministry of Health has been asked to suspend discussions on the draft of the 2024 Tobacco and E-cigarette Product Safety Regulation (RPMK). The regulation has been criticized for restricting the market space for tobacco and e-cigarette products, and potentially harming Indonesia's tobacco farming and tobacco industry chain.


According to reports, this suggestion was put forward during a national dialogue event held at the Ashley Hotel in Jakarta on September 17 by pesantren and the Community Development Center (P3M).


The event was attended by a total of 50 representatives from government agencies, farmers' associations, trade unions, retailers associations, businesses, tobacco industry associations, civil society alliances, academia, religious leaders, and media. P3M Director Sarmidi Husna expressed concerns about the RPMK 2024 draft primarily due to its proposed plain packaging regulations, which are seen as restrictive to the tobacco industry. Husna noted that there was insufficient public participation in the drafting process, making it unrepresentative.


Husna further explained that some provisions in the draft may cause harm to tobacco farmers, small and medium-sized enterprises, various associations, and the tobacco industry, triggering strong opposition from various parties.


Benguet Saragih, from the Disease Control Working Group at the Ministry of Health, clarified that RPMK 2024 is not aimed at getting people to quit smoking, but rather is intended to prevent children from smoking.


In response, the Chairman of the National Association of Islamic Scholars (PBNU), Miftah Faqih, emphasized that the process of formulating any laws must include a balanced participation from all parties and focus on the common good, otherwise these laws will be ineffective and unfair. The representative of the Ministry of Industry, Nugraha Prasetya Yogi, also stated that the Ministry of Industry was not included in the previous law-making process, which is very detrimental to trade and industry.


Union representative Sudarto pointed out that since the enactment of the 2003 Health Law and Government Regulation No. 28 of 2004, tobacco regulations have gradually been implemented, significantly impacting the tobacco leaf and tobacco products industry. Sudarto emphasized that industrial policies and tax policies have also been used to suppress legal tobacco consumption, leading to the frequent appearance of illegal tobacco products.


Gunawan from the Indonesian Commission for Social Justice and Human Rights (IHCS) is calling for the coordination of existing regulations and laws to protect the interests of tobacco farmers. Indonesian parliament member Muhammad Misbakhun mentioned that the influence of international giants has caused local economies and tobacco farmers to go bankrupt, and therefore calls for the government to be a facilitator in finding a solution to the problem.


Representatives from the Indonesian Tobacco Association, Budiman, believe that restricting the sale of tobacco products will have negative effects on production, employment, and raw material sourcing. Additionally, Kusnasi Mudi, the Secretary General of the National Tobacco Growers Association (APTI), also stated that the government needs to reexamine this regulation and communicate with the entire industry chain to prevent significant impact on the future development of the industry.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10